Results 131 to 140 of about 72,133 (313)

Adverse in‐hospital outcomes in patients with paraplegia who undergo radical prostatectomy

BJU International, Volume 137, Issue 1, Page 209-215, January 2026.
Objective To test for the association between paraplegia and perioperative complications as well as in‐hospital mortality after radical prostatectomy (RP) for non‐metastatic prostate cancer. Patients and Methods We identified patients who underwent RP (National Inpatient Sample [NIS] 2000–2019), stratified according to paraplegia status.
Andrea Marmiroli, Francesco Di Bello, Natali Rodriguez Peñaranda, Mattia Longoni, Quynh Chi Le, Fabian Falkenbach, Michele Nicolazzini, Calogero Catanzaro, Zhe Tian, Jordan A. Goyal, Stefano Luzzago, Francesco Alessandro Mistretta, Mattia Piccinelli, Fred Saad, Shahrokh F. Shariat, Alberto Briganti, Felix K. H. Chun, Salvatore Micali, Nicola Longo, Markus Graefen, Carlotta Palumbo, Riccardo Schiavina, Gennaro Musi, Pierre I. Karakiewicz   +23 more
wiley   +1 more source

Radical cystectomy for elderly patients with bladder carcinoma [PDF]

, 1998
ARSENIO J. FIGUEROA, John P. Stein, Ming G. Dickinson, Eila C. Skinner, Duraiyah Thangathurai, Maged Mikhail, Stuart D. Boyd, Gary Lieskovsky, Donald G. Skinner   +8 more
openalex   +1 more source

Grading of bladder cancer: updates, controversies and practical solutions

Histopathology, Volume 88, Issue 1, Page 86-107, January 2026.
This review provides a comprehensive overview of the commonly used grading schemes for papillary bladder neoplasms. Bladder cancer grading provides important prognostic information to clinicians, and the assigned grade is used as a variable in risk stratification models.
Michelle R Downes, Theodorus H van der Kwast, Antonio Lopez‐Beltran, Liang Cheng   +3 more
wiley   +1 more source

Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy

Acta Oncologica
Background and purpose: Recommended treatment of urothelial muscle-invasive bladder cancer (MIBC) is cisplatin-based neoadjuvant chemotherapy (NAC) followed by cystectomy, but there are challenges with low utilization of NAC.
Hege S. Haugnes, Hakon Kjaeve, Eivind Bjerkaas, Ragnhild Hellesnes, Line Hjelle, Magnus Larsen   +5 more
doaj   +1 more source

MP49-02 THE EFFECT OF SURGICAL COMPLEXITY ON PERIOPERATIVE OUTCOMES OF ROBOT-ASSISTED RADICAL CYSTECTOMY [PDF]

, 2020
Ahmed S. Elsayed, Naif A. Aldhaam, Zhe Jing, Jennifer Osei, Mohammad Durrani, Zachary Kurbiel, Michael Mostowy, Alat Siam, Tarik Babar, Ahmed Hussein, Khurshid A. Guru   +10 more
openalex   +1 more source

Artificial intelligence in genitourinary pathology

Histopathology, Volume 88, Issue 1, Page 353-373, January 2026.
Artificial intelligence (AI) is now practical in genitourinary pathology. We synthesize evidence and economics into a two‐part playbook: VALIDATED (governance) and ORCHESTRATE (operations), to safely deploy AI tools across prostate, bladder, kidney and testis.
Ankush U Patel, Anil V Parwani, Swati Satturwar   +2 more
wiley   +1 more source

Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials [PDF]

, 2019
Do Kyung Kim, Joo Yong Lee, Jae Hung Jung, Yoon Soo Hah, Kang Su Cho   +4 more
openalex   +1 more source

Neoadjuvant Under‐Dilated TIPS: Expanding Surgeries for Extrahepatic Malignancies in Patients With Cirrhosis and CSPH

Liver International, Volume 46, Issue 1, January 2026.
ABSTRACT Background & Aims Portal hypertension is a major challenge in patients with cirrhosis requiring surgery. This study aimed to evaluate the efficacy of under‐dilated neoadjuvant transjugular intrahepatic portosystemic shunt (U.N‐TIPS) in enabling elective extrahepatic oncologic surgery in patients with cirrhosis and clinically significant portal
Dario Saltini, Davide Roccarina, Marco Senzolo, Cristian Caporali, Fabrizio Fanelli, Marcello Bianchini, Federico Casari, Angelica Ingravallo, Silvia Aspite, Tomas Guasconi, Antonio Piscopo, Andrea Salome Velasco Mayorga, Barbara Catellani, Gian Piero Guerrini, Stefano Di Sandro, Fabio Staderini, Umberto Cillo, Fabrizio Di Benedetto, Antonio Colecchia, Fabio Marra, Patrizia Burra, Francesco Vizzutti, Filippo Schepis   +22 more
wiley   +1 more source

Enhanced recovery after surgery (ERAS) in patients treated with radical cystectomy

, 2020
Wojciech Krajewski, Romuald Zdrojowy
openalex   +1 more source

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract The therapeutic landscape for renal cell carcinoma (RCC) and urinary tract cancer (UTC) has transformed dramatically, creating complexity in treatment selection and sequencing. The 2025 Advanced Urologic Cancer Consensus Conference was convened to establish evidence‐based expert consensus recommendations for optimal management.
Rana R. McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges, Andrea Apolo, Michael B. Atkins, Rick Bangs, Kathryn E. Beckermann, Joaquim Bellmunt, Stephanie A. Berg, Mehmet A. Bilen, David Braun, Maria I. Carlo, Jason Efstathiou, Matthew Galsky, Petros Grivas, Shilpa Gupta, Naomi Haas, A. Ari Hakimi, Hans Hammers, Daniel Y. C. Heng, Michelle Hirsch, Gopakumar Iyer, Eric Jonasch, Vadim S. Koshkin, Oleksandr Kryvenko, Bryan Lewis, Roger Li, Surena Matin, Benjamin Maughan, David F. McDermott, Bradley McGregor, Joshua Meeks, Matthew Milowsky, Robert Motzer, Andrea Necchi, Dan Petrylak, Sima Porten, Thomas Powles, Brian Rini, Brian Shuch, Arlene Siefker‐Radtke, Guru Sonpavde, S. Srikala Sridhar, Cristina Suarez, Chad Tang, Abhishek Tripathi, Michiel S. Van Der Heijden, Martin Voss, Wenxin Xu, Tian Zhang, Jonathan Rosenberg, Toni K. Choueiri   +53 more
wiley   +1 more source